Unusual complication of aluminum phosphide poisoning: Development of hemolysis and methemoglobinemia and its successful treatment
Current diagnostic techniques are not yet capable of accurately tracking nanomaterial distribution, metabolic pathways, and interactions with biomolecules within the body, making it difficult to tailor nanomaterial-based treatments to individual patients
You are flooding cells with cysteine
The clinical trial of glutamine antimetabolites DRP-104 is under way (NCT06027086)
AOD-9604 10mg 59,95 AOD-9604 10mg Research Grade Synthetic reference peptide EU Stock Fast EU Shipping Research-Only Notice Research-Only Notice For laboratory research use only
While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)